Get the Stockscreener App
3.65
0.82%
-0.03
After Hours:
3.65
Health Catalyst Inc stock is traded at $3.65, with a volume of 448.15K.
It is down -0.82% in the last 24 hours and down -3.18% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$3.68
Open:
$3.63
24h Volume:
448.15K
Relative Volume:
0.84
Market Cap:
$254.04M
Revenue:
$299.48M
Net Income/Loss:
$-86.45M
P/E Ratio:
-2.4333
EPS:
-1.5
Net Cash Flow:
$-17.32M
1W Performance:
-5.19%
1M Performance:
-3.18%
6M Performance:
-35.17%
1Y Performance:
-50.47%
1-Day Range:
$3.62
$3.78
1-Week Range:
$3.62
$4.115
52-Week Range:
$3.49
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
3.65 | 256.13M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
284.20 | 46.88B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
56.59 | 10.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
97.00 | 8.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
58.75 | 11.03B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.98 | 6.17B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
What catalysts could drive Health Catalyst Inc. stock higher in 2025Wealth Building Insights With Low Risk - jammulinksnews.com
New Product Launches: Will They Boost Health Catalyst Inc. Stock in 2025Consistent Income Focused Trade List Analyzed - metal.it
Health Catalyst, Inc. (NASDAQ:HCAT) is favoured by institutional owners who hold 81% of the company - Yahoo Finance
Has Health Catalyst Inc. formed a bullish divergencePattern Breakout Entry Stock Forecast in Focus - metal.it
Will Health Catalyst Inc. Benefit From Sector TailwindsSmart Money Tracking Signal Generator Activated - beatles.ru
Why Health Catalyst Inc. stock attracts strong analyst attentionTriple Digit Return Stock Predictions Released - beatles.ru
Multi Factor Analysis Ranks Health Catalyst Inc. as Strong BuyMomentum Based Equity Trading Plans Reviewed - beatles.ru
Momentum Screeners Rank Health Catalyst Inc. in Top 5 TodayTrade Insight With Community Collaboration Supported - metal.it
Is Health Catalyst Inc. Stock a Good Fit for Conservative InvestorsWeekly Stock Watch With Growth Focus Expanded - metal.it
3 Reasons to Avoid HCAT and 1 Stock to Buy Instead - Yahoo Finance
Top Risks to Consider Before Buying Health Catalyst Inc. StockFree Real-Time Stock Data - metal.it
How does Health Catalyst Inc. compare to its industry peersMaximize gains with data-driven stock picks - jammulinksnews.com
What risks could impact Health Catalyst Inc. stock performanceFree Access to Community - metal.it
Wells Fargo Raises PT on Health Catalyst, Inc. (HCAT); Maintains ‘Buy’ Rating - MSN
Health Catalyst's Long-Term Growth Potential: A Strategic Play in Healthcare Data Analytics - AInvest
Health Catalyst Raises PT to $10, Maintains 'Buy' Rating - AInvest
What analysts say about Health Catalyst Inc. stockTremendous growth potential - PrintWeekIndia
Is Health Catalyst Inc. a good long term investmentHigh-profit trading signals - PrintWeekIndia
Does Health Catalyst Inc. stock pay reliable dividendsFree Wealth Planning Blueprint - jammulinksnews.com
11 Most Undervalued Cloud Stocks Under $10 According to Hedge Funds - Insider Monkey
What drives Health Catalyst Inc. stock priceSuperior stock growth - Autocar Professional
How to Take Advantage of moves in (HCAT) - news.stocktradersdaily.com
Health Catalyst Inc. Stock Analysis and ForecastRapid market gains - jammulinksnews.com
Empowering Growth: Care Coordination Prioritization Market - openPR.com
Health Catalyst (HCAT) Stock Sees 6.6% Increase Amid Earnings OptimismNews and Statistics - IndexBox
Why Health Catalyst (HCAT) Stock Is Up Today - Yahoo Finance
Health Catalyst Announces Q2 2025 Earnings Release and Conference Call on August 7, 2025 - AInvest
Why Health Catalyst Inc. stock is on top investor watchlistsRisk Adjusted Stock Signals - Newser
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.26%
3.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):